![Cann Group Limited logo](/logos/CAN.AX.webp)
Cann Group Limited
ASX:CAN.AX
Overview | Financials
Company Name | Cann Group Limited |
Symbol | CAN.AX |
Currency | AUD |
Price | 0.037 |
Market Cap | 17,289,212 |
Dividend Yield | 0% |
52-week-range | 0.027 - 0.19 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Peter Koetsier |
Website | https://www.canngrouplimited.com |
An error occurred while fetching data.
About Cann Group Limited
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD